- Home
- FDX vs MRNA Comparison
FDX vs MRNA Comparison
Compare FDX & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDX | MRNA |
|---|---|---|
| Founded | 1971 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.8B | 61.6B |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FDX | MRNA |
|---|---|---|
| Price | $285.07 | $199.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 12 |
| Target Price | ★ $376.67 | $34.27 |
| AVG Volume (30 Days) | 1.3M | ★ 14.5M |
| Earning Date | 03-19-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | 10.35 | ★ 21.77 |
| EPS | ★ 18.55 | N/A |
| Revenue | ★ $65,450,000,000.00 | $19,263,000,000.00 |
| Revenue This Year | $7.43 | $9.36 |
| Revenue Next Year | $4.96 | $15.43 |
| P/E Ratio | $15.07 | ★ N/A |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $224.61 | $22.28 |
| 52 Week High | $413.87 | $195.71 |
Technical Indicators
Market Signals| Indicator | FDX | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 29.51 | 77.18 |
| Support Level | $270.80 | $43.35 |
| Resistance Level | $320.51 | N/A |
| Average True Range (ATR) | 6.65 | 10.92 |
| MACD | -3.05 | 3.07 |
| Stochastic Oscillator | 13.26 | 98.19 |
Price Performance
Historical ComparisonAbout FDX FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. Following the June 2026 spinoff of FedEx Freight (less-than-truckload shipping), the firm's Federal Express segment-which houses the core package delivery operations-makes up more than 95% of total revenue (previously 87%). The remainder stems from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016, boosting its presence across Europe. TNT was previously the fourth-largest global parcel delivery provider.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.